Suchergebnisse - "Callahan, Alfred"

PubPharm (41)

1

Reply : Hemorrhagic Stroke, All-Cause Death, and Intensive LDL-C Lowering: Evidence From SPARCL and Beyond

enthalten in: Journal of the American College of Cardiology | 2020

von Szarek, M. | Amarenco, P. | Callahan, A. | +4

CommentOn: J Am Coll Cardiol. 2020 May 5;75(17):2110-2118. - PMID 32194196

2

Atorvastatin Reduces First and Subsequent Vascular Events Across Vascular Territories : The SPARCL Trial

enthalten in: Journal of the American College of Cardiology | 2020

von Szarek, M. | Amarenco, P. | Callahan, A. | +7

CommentIn: J Am Coll Cardiol. 2020 May 5;75(17):2119-2121. - PMID 32209335

3

Effect of high-dose atorvastatin on renal function in subjects with stroke or transient ischemic attack in the SPARCL trial

enthalten in: Stroke | 2014

von Amarenco, P. | Callahan, A. | Campese, V. | +7

4

Prediction of major vascular events after stroke : the stroke prevention by aggressive reduction in cholesterol levels trial

enthalten in: Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association | 2014

von Ovbiagele, B. | Goldstein, L. | Amarenco, P. | +7

5

Prediction of Major Vascular Events after Stroke: The Stroke Prevention by Aggressive Reduction in Cholesterol Levels Trial

enthalten in: Journal of stroke and cerebrovascular diseases | 2014

von Ovbiagele, B. | Goldstein, L. | Amarenco, P. | +6

6

Risk of stroke and cardiovascular events after ischemic stroke or transient ischemic attack in patients with type 2 diabetes or metabolic syndrome : secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial

enthalten in: Archives of neurology | 2011

von Callahan, A. | Amarenco, P. | Goldstein, L. | +11

7

Risk of Stroke and Cardiovascular Events After Ischemic Stroke or Transient Ischemic Attack in Patients With Type 2 Diabetes or Metabolic Syndrome: Secondary Analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Trial

enthalten in: Archives of neurology | 2011

von Callahan, A. | Amarenco, P. | Goldstein, L. | +10

8

Coronary heart disease risk in patients with stroke or transient ischemic attack and no known coronary heart disease : findings from the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial

enthalten in: Stroke | 2010

von Amarenco, P. | Goldstein, L. | Sillesen, H. | +7

9

Coronary Heart Disease Risk in Patients With Stroke or Transient Ischemic Attack and No Known Coronary Heart Disease: Findings From the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Trial

enthalten in: Stroke | 2010

von Amarenco, P. | Goldstein, L. | Sillesen, H. | +6

10

Coronary heart disease risk in patients with stroke or transient ischemic attack and no known coronary heart disease : findings from the stroke prevention by aggressive reduction in cholesterol levels (SPARCL) trial

enthalten in: Stroke | [March 2010]

von Amarenco, P. | Goldstein, L. | Sillesen, H. | +6

1
2
3
4
5
Nächster »
[5]